Other
Hypoxia exposure
Hypoxia exposure is an intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Early Phase 1First-in-human
2(100.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Active, not recruiting1
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 12 (100.0%)
Trials by Status
active_not_recruiting133%
unknown133%
completed133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruitingearly_phase_1
Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity
NCT04436731
unknown
Effect of Acute Sleep Restriction on Responses to Hypoxia
NCT05563688
completedearly_phase_1
Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)
NCT01872533
Clinical Trials (3)
Showing 3 of 3 trials
NCT04436731Early Phase 1
Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity
NCT05563688
Effect of Acute Sleep Restriction on Responses to Hypoxia
NCT01872533Early Phase 1
Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3